Evidence map›Paper›PMID 21633022›Full record

ArticleThe American journal of tropical medicine and hygiene2011

AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.

Rebecca Dillingham, Paul Leger, Carole-Anne Beauharnais, Erica Miller, Angela Kashuba, Steven Jennings, Kathryn Dupnik, Amidou Samie, Etna Eyma, Richard Guerrant and 2 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rebecca DillinghamUniversity of Virginia School of Medicine, Center for Global Health, Charlottesville, VA 22903, USA. rd8v@virginia.edu
Paul Leger
Carole-Anne Beauharnais
Erica Miller
Angela Kashuba
Steven Jennings
Kathryn Dupnik
Amidou Samie
Etna Eyma
Richard Guerrant
Jean Pape
Daniel Fitzgerald

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000018 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHNSON, WARREN DOUGLAS · 1988 to 2012
$16.1M
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
HAITI AIDS RESEARCH TRAINING: MODELS TO IMPLEMENTATIONU2RTW006901 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHNSON, WARREN DOUGLAS · 2004 to 2009
$1.1M
EAEC Infection in HIV-infected Patients in HaitiK23AI077339 · NIAID · UNIVERSITY OF VIRGINIA · PI DILLINGHAM, REBECCA A. · 2008 to 2012
$644k
AIDS Diarrhea and Antiretroviral Drug AbsorptionR21AI064021 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2005 to 2006
$481k
FIC NIH HHS D43 TW000018FIC NIH HHS R25 TW009337FIC NIH HHS TW00018FIC NIH HHS TW006901NIAID NIH HHS AI007046NIAID NIH HHS AI064021NIAID NIH HHS AI077339NIAID NIH HHS AI50410NIAID NIH HHS K23 AI077339NIAID NIH HHS P30 AI050410NIAID NIH HHS R21 AI064021NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

Diarrhea in patients with acquired immunodeficiency syndrome (AIDS) may cause malabsorption of medications and failure of antiretroviral therapy (ART). We prospectively evaluated human immunodeficiency virus-1 (HIV-1)-infected patients with and without chronic diarrhea initiating ART in Haiti. We report mean plasma antiretroviral concentrations at 2 and 4 weeks. We measured plasma HIV-1 RNA levels at four points. Fifty-two HIV-1-infected patients (26 matched pairs) were enrolled. No differences in antiretroviral concentrations were detected. At week 24, 18/25 (72%) cases and 16/24 (68%) controls had undetectable plasma HIV-1 RNA levels (P = 0.69). Patients with plasma HIV-1 RNA levels > 50 copies/mL at week 24 had lower early efavirenz concentrations than patients with undetectable HIV-1 RNA (2,621 ng/mL versus 5,278 ng/mL; P = 0.02). Diarrhea at ART initiation does not influence plasma concentrations of the medications evaluated. Virologic outcome at Week 24 does correlate with efavirenz concentrations early in therapy but not with the presence of chronic diarrhea.

Indexed as

Acquired Immunodeficiency SyndromeAdultAlkynesAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBenzoxazinesCD4 Lymphocyte CountCyclopropanesDiarrheaFemaleHaitiHIV-1HIV InfectionsHumansMaleMatched-Pair AnalysisAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesefavirenzRNA, Viral

Identifiers

PMID21633022
PMCPMC3110379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.